% alzhub.org topic: context
% Source: https://alzhub.org/topic/context
% 3 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{portamas2025-41368997,
  author  = {Porta-Mas, C. and Grau-Rivera, O. and Gispert, J. D. and Blasco, G. S. and Sánchez-Benavides, G.},
  title   = {{Validation status of cognitive digital assessments by the FDA BEST framework and context of use in preclinical AD studies: A systematic review}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2025},
  doi     = {10.1002/alz.70753},
  pmid    = {41368997},
  url     = {https://doi.org/10.1002/alz.70753}
}

@article{bischof2021-33590274,
  author  = {Bischof, G. N. and Dodich, A. and Boccardi, M. and van Eimeren, T. and Festari, C. and Barthel, H. and Hansson, O. and Nordberg, A. and others},
  title   = {{Clinical validity of second-generation tau PET tracers as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework}},
  journal = {European journal of nuclear medicine and molecular imaging},
  year    = {2021},
  doi     = {10.1007/s00259-020-05156-4},
  pmid    = {33590274},
  url     = {https://doi.org/10.1007/s00259-020-05156-4}
}

@article{wolters2021-33547556,
  author  = {Wolters, E. E. and Dodich, A. and Boccardi, M. and Corre, J. and Drzezga, A. and Hansson, O. and Nordberg, A. and Frisoni, G. B. and others},
  title   = {{Clinical validity of increased cortical uptake of [18F]flortaucipir on PET as a biomarker for Alzheimer's disease in the context of a structured 5-phase biomarker development framework}},
  journal = {European journal of nuclear medicine and molecular imaging},
  year    = {2021},
  doi     = {10.1007/s00259-020-05118-w},
  pmid    = {33547556},
  url     = {https://doi.org/10.1007/s00259-020-05118-w}
}